Joseph S. Zakrzewski - 27 Nov 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph S. Zakrzewski
Issuer symbol
ANTX
Transactions as of
27 Nov 2024
Net transactions value
+$2,800
Form type
4
Filing time
27 Nov 2024, 16:16:41 UTC
Previous filing
20 Nov 2024
Next filing
23 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $2,800 +2,000 +1.6% $1.40 125,199 27 Nov 2024 Direct
holding ANTX Common Stock 405,880 27 Nov 2024 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Z3 Trust, for which the Reporting Person is a trustee.